Genelux GNLX
NASDAQ GNLX
$2.48 -0.04 (-1.59%)
At close: Sep 10, 2026 · 4:00 PM EDT

Genelux (GNLX) Non-Current Assets (2022 - 2026)

Genelux (GNLX) posted Non-Current Assets of $5.6 million for Q1 2026, up 44.16% on a QoQ basis from $3.9 million in Q4 2025.

Analysis

Genelux (GNLX) Non-Current Assets (2022 - 2026) Analysis & Trends

Genelux has reported Non-Current Assets for 5 years, with the latest figure at $5.6 million in Q1 2026.

  • On a quarterly basis, Non-Current Assets changed N/A year-over-year to $5.6 million in Q1 2026; TTM through Sep 2025 was $3.4 million, a 20.17% decrease from a year earlier, with the FY2025 full-year figure at $3.9 million, up 23.01% from the prior year.
  • Non-Current Assets was $5.6 million for Q1 2026 at Genelux, up from $3.9 million in the prior quarter.
  • The five-year high for Non-Current Assets was $10.3 million in Q2 2024, with the low at $2.9 million in Q3 2023.
  • Average Non-Current Assets over 5 years is $4.3 million, with a median of $3.6 million recorded in 2022.
  • The sharpest annual moves came in 2024 and 2025: Non-Current Assets soared 48.74% in 2024, then sank 70.78% in 2025.
  • Over 5 years, Non-Current Assets stood at $3.6 million in 2022, then climbed by 1.4% to $3.7 million in 2023, then slipped by 14.15% to $3.2 million in 2024, then rose by 23.01% to $3.9 million in 2025, then soared by 44.16% to $5.6 million in 2026.
  • The last three Non-Current Assets figures came in at $5.6 million (Q1 2026), $3.9 million (Q4 2025), and $3.4 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 60.68 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 35.42 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 14.88 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 23.28 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.96 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 5.15 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 938.60 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 24.78 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 564.41 Mn
10 Genelux 108.17 Mn 108.17 Mn - 5.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 5.62 Mn
Dec 31, 2025 3.90 Mn
Sep 30, 2025 3.44 Mn
Jun 30, 2025 3.01 Mn
Dec 31, 2024 3.17 Mn
Sep 30, 2024 4.30 Mn
Jun 30, 2024 10.31 Mn
Mar 31, 2024 3.47 Mn
Dec 31, 2023 3.69 Mn
Sep 30, 2023 2.89 Mn
Dec 31, 2022 3.64 Mn